CoChat

Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI

Sabbadin, C., Andrisani, A., Zermiani, M., Donà, G., Bordin, L., Ragazzi, E., Boscaro, M., Ambrosini, G., Armanini, D. · 2016 · Journal of Endocrinological Investigation

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Purpose Spironolactone (SP) is an effective treatment for polycystic ovary syndrome (PCOS), but it is often associated with menstrual abnormalities whose mechanism is still under investigation. In this study, we investigated the serum sex steroids and endometrial thickness in 30 PCOS patients, before and after one-month 100 mg SP treatment.Methods Serum FSH, LH, estradiol, progesterone and endometrial thickness were evaluated at the 14th and 16th day of the menstrual cycle, before and during short-term SP treatment. According to the presence (15 cases) or absence (15 cases) of menstrual bleeding at the 14th day during SP, the patients were divided into two groups, which were then compared using a two-tailed Student's t test.Results Serum estradiol and endometrial thickness were lower than pretreatment at both determinations in all patients, but patients with bleeding had significantly lower estradiol values than non-bleeding ones, both before and after therapy. Endometrial thickness was significantly lower in the bleeding group compared with non-bleeding group only at the 16th day of the cycle. These differences were significant, even though the values of estradiol and endometrial thickness remained in the normal range.Conclusions SP therapy can reduce the values of estradiol and the endometrial thickness in patients with PCOS compared with pretreatment, but PCOS patients with bleeding had pretreatment estradiol values lower than the patients who did not complain of this side effect. Intermenstrual abnormalities may represent the low estrogen impregnation of endometrium due to SP, whose mechanism is complex, involving several factors, such as the effects of some metabolites of SP on estradiol and progesterone production, on their receptors, and the individual metabolism of SP in vivo.

Overview

Integrity signals

Registry

Crossref · 10.1007/s40618-016-0466-0

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 21 references

Research works printed but not linked: 1

  1. Smals AGH, Kloppenborg PWC, Hoefnagels WH, Drayer JIM, Benraad ThJ (1978) Pituitary and gonadal function in high-dose spironolactone-treated premenopausal women. Aldosterone antagonists in clinical medicine. Proceedings of the Searle symposium, Nice 303–307

Cited by

See all 33

Metadata

Authors
Sabbadin, C., Andrisani, A., Zermiani, M., Donà, G., Bordin, L., Ragazzi, E., Boscaro, M., Ambrosini, G., & Armanini, D.
Affiliations
University of Padua (IT)
Corresponding author
Armanini, D.
Venue
Journal of Endocrinological Investigation
Published
2016-04-12
Volume
39
Issue
9
Pages
1015-1021
ISSN
  • 0391-4097 (ISSN-L)
  • 1720-8386
OpenAlex
W2341339272
Cited by
33
References
21
Citations by year
2026: 5 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 6 · 2021: 3 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 3
FWCI
4.43
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Endocrinological Investigation (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Funders
Università degli Studi di Padova
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
Keywords
spironolactone, polycystic ovary syndrome, metrorrhagia, menstrual disorders, estradiol, endometrial thickness, normal body mass index
MeSH terms
Adult, Mineralocorticoid Receptor Antagonists, Female, Humans, Menstrual Cycle, Metrorrhagia, Polycystic Ovary Syndrome, Spironolactone, Ultrasonography, Body Mass Index, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI. https://app.cochat.ai/papers/10.1007/s40618-016-0466-0
The paper
Sabbadin, C., Andrisani, A., Zermiani, M., Donà, G., Bordin, L., Ragazzi, E., Boscaro, M., Ambrosini, G., & Armanini, D. (2016). Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI. Journal of Endocrinological Investigation. https://doi.org/10.1007/s40618-016-0466-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.